Literature DB >> 24354958

Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients.

Frida Emanuelsson1, Berndt E B Claesson, Lars Ljungström, Michael Tvede, Kjell-Arne Ung.   

Abstract

BACKGROUND: Recurrent Clostridium difficile infection (CDI) is a significant problem due to its increased incidence and severity. Failure rates for standard antibiotic therapies are high. In our hospital, faecal microbiota transplantation (FMT), or instillation of a culture mixture of known enteric bacteria in saline as rectal bacteriotherapy (RBT), has long been used as 'rescue therapy' in patients with recurrent disease, in whom repeated courses of standard antibiotic treatment have failed. We wanted to evaluate the effectiveness of FMT and RBT for recurrent CDI.
METHODS: The records of 31 patients treated with either FMT or RBT for recurrent CDI were reviewed retrospectively. FMT was based on faecal donation by a close relative and RBT on a defined saline mixture of 10 individually cultured enteric bacterial strains originally isolated from healthy persons. Both types of instillation were carried out through a rectal catheter. FMT (500 ml) was given as 1 installation. RBT (200 ml) was given as 2 or 3 installations with an interval of 2 days between courses. Treatment success was defined as a sustained loss of symptoms and discontinuation of diarrhoea within 3 days.
RESULTS: Of 31 patients, 23 (74%) responded successfully to the treatment: 16 of 23 (70%) receiving FMT and 7 of 8 (88%) receiving RBT.
CONCLUSION: We found FMT to be effective in patients with recurrent CDI. RBT based on a predefined bacterial suspension was as effective as or better than FMT based on faecal donation; however, multiple installations may be needed.

Entities:  

Mesh:

Year:  2013        PMID: 24354958     DOI: 10.3109/00365548.2013.858181

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  22 in total

Review 1.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

Review 2.  The potential for emerging therapeutic options for Clostridium difficile infection.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Gut Microbes       Date:  2014

Review 3.  THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION.

Authors:  Michael B Edmond
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

Review 4.  Microbiota-mediated inflammation and antimicrobial defense in the intestine.

Authors:  Silvia Caballero; Eric G Pamer
Journal:  Annu Rev Immunol       Date:  2015-01-02       Impact factor: 28.527

5.  Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections.

Authors:  Ying Taur; Eric G Pamer
Journal:  Nat Med       Date:  2014-03       Impact factor: 53.440

Review 6.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.

Authors:  Mohit Girotra; Shashank Garg; Rohit Anand; Yang Song; Sudhir K Dutta
Journal:  Dig Dis Sci       Date:  2016-07-22       Impact factor: 3.199

8.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.

Authors:  Krishna Rao; Kavitha Santhosh; Jill A Mogle; Peter D R Higgins; Vincent B Young
Journal:  Infect Dis (Lond)       Date:  2016-05-20

Review 9.  Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Authors:  Jennifer K Spinler; Caná L Ross; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-13       Impact factor: 3.331

Review 10.  Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation.

Authors:  M Nedim Ince; Bruce R Blazar; Michael B Edmond; Guido Tricot; Michael J Wannemuehler
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.